chloroquine has been researched along with Coagulation Disorders, Blood in 4 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients showed no signs of overt disseminated intravascular coagulation (DIC) in their laboratory analysis." | 1.56 | Severe arterial thromboembolism in patients with Covid-19. ( Buise, MP; Canta, LR; Hendriks, J; Krietemeijer, GM; Lameijer, JRC; Nijziel, MR; Troquay, SAM; van Berckel, MMG; van Houte, J; Yo, LSF, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gouveia, CC | 1 |
| Campos, L | 1 |
| Lameijer, JRC | 1 |
| van Houte, J | 1 |
| van Berckel, MMG | 1 |
| Canta, LR | 1 |
| Yo, LSF | 1 |
| Nijziel, MR | 1 |
| Krietemeijer, GM | 1 |
| Troquay, SAM | 1 |
| Buise, MP | 1 |
| Hendriks, J | 1 |
| Cummins, D | 1 |
| Faint, R | 1 |
| Yardumian, DA | 1 |
| Dawling, S | 1 |
| Mackie, I | 1 |
| Machin, SJ | 1 |
| Reid, HA | 1 |
| Sucharit, P | 1 |
1 review available for chloroquine and Coagulation Disorders, Blood
| Article | Year |
|---|---|
Coronavirus Disease 2019: Clinical Review.
Topics: Adenosine Monophosphate; Alanine; Amides; Animals; Antiviral Agents; Azithromycin; Betacoronavirus; | 2020 |
3 other studies available for chloroquine and Coagulation Disorders, Blood
| Article | Year |
|---|---|
Severe arterial thromboembolism in patients with Covid-19.
Topics: Aged, 80 and over; Blood Coagulation; Blood Coagulation Disorders; Chloroquine; COVID-19; COVID-19 D | 2020 |
The in-vitro and ex-vivo effects of chloroquine sulphate on platelet function: implications for malaria prophylaxis in patients with impaired haemostasis.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adult; Blood Coagulation Disorders; Blood Platelets; | 1990 |
Ancrod, heparin, and -aminocaproic acid in simian Knowlesi malaria.
Topics: Aminocaproates; Animals; Anticoagulants; Blood Coagulation Disorders; Chloroquine; Fibrinolytic Agen | 1972 |